1. Home
  2. CODX vs NUAI Comparison

CODX vs NUAI Comparison

Compare CODX & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • NUAI
  • Stock Information
  • Founded
  • CODX 2013
  • NUAI N/A
  • Country
  • CODX United States
  • NUAI United States
  • Employees
  • CODX N/A
  • NUAI N/A
  • Industry
  • CODX Medical/Dental Instruments
  • NUAI Oil & Gas Production
  • Sector
  • CODX Health Care
  • NUAI Energy
  • Exchange
  • CODX Nasdaq
  • NUAI Nasdaq
  • Market Cap
  • CODX 9.8M
  • NUAI 10.4M
  • IPO Year
  • CODX 2017
  • NUAI N/A
  • Fundamental
  • Price
  • CODX $0.42
  • NUAI $0.45
  • Analyst Decision
  • CODX Buy
  • NUAI
  • Analyst Count
  • CODX 2
  • NUAI 0
  • Target Price
  • CODX $5.50
  • NUAI N/A
  • AVG Volume (30 Days)
  • CODX 13.6M
  • NUAI 11.2M
  • Earning Date
  • CODX 11-06-2025
  • NUAI 11-14-2025
  • Dividend Yield
  • CODX N/A
  • NUAI N/A
  • EPS Growth
  • CODX N/A
  • NUAI N/A
  • EPS
  • CODX N/A
  • NUAI N/A
  • Revenue
  • CODX $1,003,653.00
  • NUAI $718,761.00
  • Revenue This Year
  • CODX N/A
  • NUAI N/A
  • Revenue Next Year
  • CODX $31.58
  • NUAI N/A
  • P/E Ratio
  • CODX N/A
  • NUAI N/A
  • Revenue Growth
  • CODX N/A
  • NUAI 14.80
  • 52 Week Low
  • CODX $0.23
  • NUAI $0.32
  • 52 Week High
  • CODX $1.40
  • NUAI $12.29
  • Technical
  • Relative Strength Index (RSI)
  • CODX 56.81
  • NUAI N/A
  • Support Level
  • CODX $0.30
  • NUAI N/A
  • Resistance Level
  • CODX $0.72
  • NUAI N/A
  • Average True Range (ATR)
  • CODX 0.06
  • NUAI 0.00
  • MACD
  • CODX 0.02
  • NUAI 0.00
  • Stochastic Oscillator
  • CODX 28.32
  • NUAI 0.00

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About NUAI New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

Share on Social Networks: